(Q36673528)

15 August 2017

Differential gene expression identifies subgroups of ovarian carcinoma (English)

1 reference

15 August 2017

2

Stefan E Pambuccian

1 reference

15 August 2017

Amy P N Skubitz

1

1 reference

PubMed ID

17145569

15 August 2017

Peter A Argenta

series ordinal

3

1 reference

PubMed ID

17145569

15 August 2017

Keith M Skubitz

series ordinal

4

1 reference

15 August 2017

1 November 2006

1 reference

15 August 2017

Translational Research

1 reference

15 August 2017

148

1 reference

15 August 2017

223-248

1 reference

15 August 2017

5

1 reference

The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Pathology of borderline (low malignant potential) ovarian tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Molecular characterisation of soft tissue tumours: a gene expression study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Differential gene expression in renal-cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Differential gene expression in leiomyosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Characterization of sarcomas by means of gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Gene expression in aggressive fibromatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Differential gene expression in liposarcoma, lipoma, and adipose tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Differential gene expression identifies subgroups of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Gene expression signature with independent prognostic significance in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Differential gene expression in ovarian carcinoma: identification of potential biomarkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Signature of a silent killer: expression profiling in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Histopathologic grading of ovarian carcinoma: a review and proposal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Grading ovarian serous carcinoma using a two-tier system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Prognostic value of histologic grading of ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Differential gene expression in uterine leiomyoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Gene expression in giant-cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Serous tumors of low malignant potential of the ovary-molecular pathology: part 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Gene expression patterns in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.06.001

10.1016/J.TRSL.2006.06.001

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17145569